- Report
- March 2026
- 150 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- June 2026
- 200 Pages
Global
From €2717EUR$2,990USD£2,335GBP
- Report
- January 2026
- 326 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- May 2026
- 150 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- May 2026
- 150 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- October 2025
- 150 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- October 2025
- 150 Pages
Global
From €5406EUR$5,950USD£4,648GBP
- Report
- April 2026
- 146 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 137 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 141 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- May 2026
- 188 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- September 2026
- 278 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- May 2026
- 185 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- May 2026
- 185 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- January 2026
- 186 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- January 2026
- 183 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- September 2026
- 193 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 193 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 180 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 188 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more